The U.S. Food and Drug Administration has issued another warning to consumers not to purchase certain eyedrop brands due to risk of eye infection.

On Jan. 31, the FDA issued an announcement warning consumers not to use South Moon, Rebright or FivFivGo eye drops because of the potential risk of eye infection.

In the announcement, the agency described the brands as copycat eyedrop brands that consumers can easily mistake for Bausch + Lomb’s Lumify brand eye drops, an over-the-counter product approved for redness relief.

“South Moon, Rebright and FivFivGo eye drops are unapproved drugs and should not be available for sale in the U.S. They claim to treat eye conditions such as glaucoma, which is treated with prescription drugs or surgery,” the FDA said in the announcement.

Read more: More eye drop recall: These eyedrops from CVS, Target, Rite Aid, Walmart should be avoided

The agency says patients who have signs or symptoms of an eye infection should talk to their healthcare provider or seek medical care immediately. The FDA recommends consumers properly discard the eyedrops.